Last 2,990 KRW
Change Today +55.00 / 1.87%
Volume 75.5K
086060 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:06 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

gene bio tech co ltd (086060) Snapshot

Open
2,950
Previous Close
2,935
Day High
3,050
Day Low
2,950
52 Week High
04/25/13 - 6,340
52 Week Low
12/23/13 - 2,405
Market Cap
20.3B
Average Volume 10 Days
78.0K
EPS TTM
102.00
Shares Outstanding
6.8M
EX-Date
12/27/13
P/E TM
29.3x
Dividend
30.00
Dividend Yield
1.00%
Current Stock Chart for GENE BIO TECH CO LTD (086060)

Related News

No related news articles were found.

gene bio tech co ltd (086060) Related Businessweek News

No Related Businessweek News Found

gene bio tech co ltd (086060) Details

GeneBioTech Co., Ltd. manufactures and sells functional feed additives in South Korea and internationally. It offers animal medicines; plant peptides; enzymes; and reducing agents, such as mycotoxins. The company is based in Gongju, South Korea.

gene bio tech co ltd (086060) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

gene bio tech co ltd (086060) Key Developments

Genebiotech Co., Ltd., Annual General Meeting, Mar 27, 2014

Genebiotech Co., Ltd., Annual General Meeting, Mar 27, 2014., at 09:00 Korea Standard Time. Location: 458-4 gapsa gyeryongmyeon. Agenda: To consider individual and consolidated financial position, statement of comprehensive income, statement of retained earnings; to consider the appointment of audit; to consider the approval of directors' remuneration limit; and to consider the approval of directors' remuneration limit.

Gene Bio Tech Co., Ltd., Annual General Meeting, Mar 26, 2013

Gene Bio Tech Co., Ltd., Annual General Meeting, Mar 26, 2013., at 09:00 Korea Standard Time. Location: small conference rooms. Agenda: To consider individual and consolidated statement of financial position, statement of comprehensive income, statement of appropriation of retained earnings; to consider election of directors; to consider directors' remuneration limit; to consider approval of the audit fees limit; to consider date of board of directors' resolution; to consider outside directors in attendance number; to consider Auditors in attendance; to consider type of shareholders' meeting annual meeting; and to consider the other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
086060:KS 2,990.00 KRW +55.00

086060 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 086060.
View Industry Companies
 

Industry Analysis

086060

Industry Average

Valuation 086060 Industry Range
Price/Earnings 98.1x
Price/Sales 19.2x
Price/Book 45.9x
Price/Cash Flow 7.1x
TEV/Sales NM Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENE BIO TECH CO LTD, please visit www.genebiotech.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.